カテゴリ： GlobalData, 医療/バイオ

タンパク尿治療薬の世界市場：治験レビュー

◆英語タイトル：Proteinuria Global Clinical Trials Review, H2, 2019
◆商品コード：GDT20FB0033
◆発行会社（リサーチ会社）：GlobalData
◆発行日：2019年12月
◆ページ数：177
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥270,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD5,000 ⇒換算￥540,000見積依頼/購入/質問フォーム
Enterprisewide Price（複数事業所内共有可）USD7,500 ⇒換算￥810,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

 【レポートの概要】

Proteinuria Global Clinical Trials Review, H2, 2019
Summary

GlobalData’s clinical trial report, “Proteinuria Global Clinical Trials Review, H2, 2019″ provides an overview of Proteinuria clinical trials scenario. This report provides top line data relating to the clinical trials on Proteinuria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Proteinuria to Genito Urinary System And Sex Hormones Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Proteinuria to Genito Urinary System And Sex Hormones Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Proteinuria Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Proteinuria 31
Sep 25, 2019: Omeros announces publication of study showing that inhibition of MASP-2, the key enzyme of the complement system’s Lectin Pathway, protects against renal injury caused by Proteinuria 31
Clinical Trial Profile Snapshots 32
Appendix 174
Abbreviations 174
Definitions 174
Research Methodology 175
Secondary Research 175
About GlobalData 176
Contact Us 176
Source 177

List of Tables
Proteinuria Therapeutics, Global, Clinical Trials by Region, 2019* 8
Proteinuria Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
Proteinuria Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Proteinuria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
Proteinuria Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
Proteinuria Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
Proteinuria Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
Proteinuria Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16
Proportion of Proteinuria to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2019* 17
Proteinuria Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
Proteinuria Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
Proportion of Proteinuria to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2019* 20
Proteinuria Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 21
Proteinuria Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 22
Proteinuria Therapeutics, Global, Clinical Trials by Phase, 2019* 23
Proteinuria Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 24
Proteinuria Therapeutics, Global, Clinical Trials by Trial Status, 2019* 25
Proteinuria Therapeutics Clinical Trials, Global, by End Point Status, 2019* 26
Proteinuria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 27
Proteinuria Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 28
Proteinuria Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 29
Proteinuria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 30
Proteinuria Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 31

List of Figures
Proteinuria Therapeutics, Global, Clinical Trials by Region, 2019* 8
Proteinuria Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
Proteinuria Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Proteinuria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
Proteinuria Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
Proteinuria Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
Proteinuria Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
Proteinuria Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16
Proportion of Proteinuria to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2019* 17
Proteinuria Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
Proteinuria Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
Proportion of Proteinuria to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2019* 20
Proteinuria Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 21
Proteinuria Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 22
Proteinuria Therapeutics, Global, Clinical Trials by Phase, 2019* 23
Proteinuria Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 24
Proteinuria Therapeutics, Global, Clinical Trials by Trial Status, 2019* 25
Proteinuria Therapeutics Clinical Trials, Global, by End Point Status, 2019* 26
Proteinuria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 27
Proteinuria Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 28
Proteinuria Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 29
Proteinuria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 30
Proteinuria Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 31

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[タンパク尿治療薬の世界市場：治験レビュー]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 尿失禁治療薬の世界市場：治験レビュー
    GDT20FB0117 / GlobalData / 2020年1月 / ...Urinary Incontinence Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Urinary Incontinence Global Clinical Trials Review, H1, 2020" provides an overview of Urinary Incontinence Clinical trials scenario. This report provides top line data relating to the clinical trials on Urinary Incontinence. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  2. 腎不全治療薬の世界市場：治験レビュー
    GDT20FB0009 / GlobalData / 2019年12月 / ...Renal Failure Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Renal Failure Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Renal Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Renal Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials)....
  3. 腎不全治療薬の世界市場：治験レビュー
    GDT20FB0013 / GlobalData / 2019年12月 / ...Renal Insufficiency Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Renal Insufficiency Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Renal Insufficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Renal Insufficiency . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing...
  4. 腎結石/結石治療薬の世界市場：治験レビュー
    GDT20FB0082 / GlobalData / 2019年12月 / ...Renal Stones/Calculi Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Renal Stones/Calculi Global Clinical Trials Review, H2, 2019" provides an overview of Renal Stones/Calculi clinical trials scenario. This report provides top line data relating to the clinical trials on Renal Stones/Calculi. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  5. 過活動膀胱治療薬の世界市場：治験レビュー
    GDT20FB0111 / GlobalData / 2020年1月 / ...Overactive Bladder Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Overactive Bladder Global Clinical Trials Review, H1, 2020" provides an overview of Overactive Bladder Clinical trials scenario. This report provides top line data relating to the clinical trials on Overactive Bladder. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  6. 末期腎疾患（末期腎疾患またはESRD）治療薬の世界市場：治験レビュー
    GDT20FB0106 / GlobalData / 2020年1月 / ...End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H1, 2020" provides an overview of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Clinical trials scenario. This report provides top line data relating to the clinical trials on End-Stage Kidney Disease (End-Stage Renal Disease or ESRD). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7),...
  7. 虚血治療薬の世界市場：治験レビュー
    GDT20FB0012 / GlobalData / 2019年12月 / ...Ischemia Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Ischemia Global Clinical Trials Review, H2, 2019" provides an overview of Treatment Ischemia clinical trials scenario. This report provides top line data relating to the clinical trials on Ischemia . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial...
  8. 気管支拡張症治療薬の世界市場：治験レビュー
    GDT20FB0053 / GlobalData / 2019年12月 / ...Bronchiectasis Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Bronchiectasis Global Clinical Trials Review, H2, 2019" provides an overview of BronchiectasisGlobal Clinical Trials Review, H2, 2019 clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchiectasis . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing...
  9. 胆石症治療薬の世界市場：治験レビュー
    GDT20FB0093 / GlobalData / 2020年1月 / ...Cholelithiasis Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Cholelithiasis Global Clinical Trials Review, H1, 2020" provides an overview of Cholelithiasis Clinical trials scenario. This report provides top line data relating to the clinical trials on Cholelithiasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are...
  10. しわ治療薬の世界市場：治験レビュー
    GDT20FB0047 / GlobalData / 2019年12月 / ...Wrinkles Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Wrinkles Global Clinical Trials Review, H2, 2019" provides an overview of Wrinkles clinical trials scenario. This report provides top line data relating to the clinical trials on Wrinkles . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆